Lataa...
Phenylethylmalonamide in essential tremor. A double-blind controlled study.
A randomised double-blind placebo-controlled trial of phenylethylmalonamide, the major metabolite of primidone was performed in eight patients with essential tremor. Phenylethylmalonamide was given in a daily dose of 400 mg for one week and 800 mg for a second week. The compound had no statistically...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1981
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC491180/ https://ncbi.nlm.nih.gov/pubmed/7031184 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|